Drug Shortage Report for FENTANYL CITRATE INJECTION, USP
| Report ID | 201035 |
| Drug Identification Number | 02501554 |
| Brand name | FENTANYL CITRATE INJECTION, USP |
| Common or Proper name | FENTANYL CITRATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | FENTANYL |
| Strength(s) | 50MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR EPIDURAL |
| Packaging size | 5 mL |
| ATC code | N01AH |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-31 |
| Estimated end date | 2023-08-31 |
| Actual end date | 2023-08-30 |
| Shortage status | Resolved |
| Updated date | 2023-08-31 |
| Company comments | Fresenius Kabi Canada regrets to advise that current stock of our Fentanyl Citrate Injection, USP 50 mcg/mL 5 mL SD Vial is short-dated. All current inventory expires July 31, 2023. Please continue to order the short-dated product while available. Please note we will be facing a supply interruption on this product effective July 31, 2023. Fresh dated inventory is expected to be available August 31, 2023. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-08-31 | English | Compare |
| v6 | 2023-08-25 | French | Compare |
| v5 | 2023-08-25 | English | Compare |
| v4 | 2023-08-18 | French | Compare |
| v3 | 2023-08-18 | English | Compare |
| v2 | 2023-08-03 | French | Compare |
| v1 | 2023-08-03 | English | Compare |
Showing 1 to 7 of 7